Protagonist Therapeutics CEO Dinesh V. Patel on our hepcidin memetic and oral IL-23 program at #ASH23

By BiotechTV | December 11, 2023

Protagonist CEO Dinesh V. Patel discusses our experience in peptide engineering, an update on the rusfertide program in polycythemia vera and the exciting future of JNJ-2113 on the sidelines of #ASH23.

WATCH VIDEO